⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

May 30, 2011Scandinavian Journal of Gastroenterology

Symptoms in patients with ulcerative colitis in remission are associated with visceral hypersensitivity and mast cell activity

Eduard A. van Hoboken Annemieke Y. Thijssen Rob Verhaaren Patrick P.J. van der Veek Frans A. Prins Hein W. Verspaget Ad Masclee

View at Publisher

Ask AI

Bookmark

Share

Abstract

Rectal hypersensitivity is associated with mucosal presence and activation of mast cells and with IBS-like symptoms in patients with UCR.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Hoboken et al. (2011) studied this question.

synapsesocial.com/papers/69dbcc6b9e6f14d6f16844b4 https://doi.org/10.3109/00365521.2011.579156

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Contributions of Pain Sensitivity and Colonic Motility to IBS Symptom Severity and Predominant Bowel HabitsCohort Study · 2008 · 156 citations
2Mechanisms of hypersensitivity in IBS and functional disordersReview · 2007 · 354 citations
3Distinctive Clinical, Psychological, and Histological Features of Postinfective Irritable Bowel SyndromeOriginal Research · 2003 · 354 citations
4Mucosal Immune Activation in Irritable Bowel Syndrome: Gender-Dependence and Association With Digestive SymptomsCase-Control Study · 2009 · 342 citations
5Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort studyCohort Study · 1999 · 375 citations

More related papers

Inflammatory Bowel Disease2002
Key role of mast cells and their major secretory products in inflammatory bowel disease2004
Correlation between endoscopic severity and the clinical activity index in ulcerative colitis1998

More from Scandinavian Journal of Gastroenterology

Primary intestinal lymphangiectasia across the lifespan: adult–pediatric comparisons of diagnostic delay, immune findings, and treatment patternsTue,
Inter-α-inhibitor heavy chain 4 levels in incident and prevalent patients with primary biliary cholangitisTue,